NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of PACS Group, Inc. (NYSE: PACS) resulting from allegations that PACS Group may have issued materially misleading business information to the investing public. So What: If you purchased PACS Group securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE: PACS) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market. PACS Group is the subject of a report issued by Hindenburg Research on November 4, 2024, titled: "PACS Group: How to Become A Billionaire In ...

Core Viewpoint - PACS Group, Inc. is under investigation for potential securities law violations following a significant drop in share price due to allegations of improper revenue inflation related to Medicare [2][4]. Group 1: Company Performance - PACS Group shares have decreased by over 50% this week [2]. - The company postponed its Q3 earnings report after a Hindenburg Research report raised concerns about the misuse of COVID waivers from 2020 to 2023 [2]. Group 2: Legal Investigation - Block & Leviton is investigating PACS Group for possible securities law violations and may file actions to recover losses for affected investors [4][7]. - Investors who have lost money in PACS Group are encouraged to contact Block & Leviton for potential recovery options [5][6]. Group 3: Investor Eligibility - Any individual who purchased PACS Group common stock and experienced a decline in share value may be eligible for recovery, regardless of whether they sold their investment [3].

SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of PACS (NYSE: PACS) investors. If you are an PACS Group, Inc. investor with losses, please fill out this form, email apolk@girardsharp.com, or call (866) 981-4800 for a free consultation. On November 4, 2024, Hindenburg Research published an article detailing PACS Group, INC’s “turnaround” formula for transforming poorl ...

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS’s Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represen ...

Core Insights - PACS Group, Inc. is under investigation for possible securities fraud following allegations of fraudulent practices related to its turnaround strategy for skilled nursing facilities [3][4] - The company's stock price experienced a significant decline of 27.8%, dropping by $11.93 to close at $31.01 per share on November 4, 2024, leading to substantial losses for investors [4] Investigation Details - Hindenburg Research released a report on November 4, 2024, accusing PACS of exploiting taxpayer-funded healthcare programs and misusing a COVID-era waiver [3] - Allegations include improper billing of Medicare Part B for unnecessary therapies and employing unlicensed administrators [3] Legal Actions - The Portnoy Law Firm has initiated an investigation and may file a class action on behalf of PACS investors who incurred losses [1] - Investors are encouraged to contact the law firm for a complimentary case evaluation and to discuss their legal rights [2][5]

ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether PACS Group, Inc. (“PACS” or the “Company”) (NYSE: PACS) complied with federal securities laws. On November 4, 2024, Hindenburg Research published a report alleging that “PACS’ ‘turnaround’ strategy largely boils down to systematically scamming taxpayer-funded healthcare programs.” Following this news, the price of the Company’s stock dropped.  If you purchased PACS stock and suffered a loss on that investment, you are e ...

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS’s Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 PACS GROUP, INC. | --- | --- | --- | |------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------|-----------------------------------------------------| | ( ...

Core Viewpoint - PACS Group, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following a critical report by Hindenburg Research, which claims the company has been involved in fraudulent activities within the skilled nursing industry [1][2]. Group 1: Investigation and Allegations - Bragar Eagel & Squire, P.C. is investigating potential claims against PACS Group on behalf of its stockholders [1]. - Hindenburg Research's report alleges that PACS Group's turnaround strategy for skilled nursing facilities is primarily based on scamming taxpayer-funded healthcare programs, following a five-month investigation that included interviews with 18 former employees and an analysis of over 900 facility-level cost reports [2]. Group 2: Market Reaction - Following the release of Hindenburg Research's report, PACS Group's stock experienced a significant decline of 27.7% on November 4, 2024 [2].